Cyclopropyl-[4-(4-methoxyphenyl)-2-propan-2-yl-5,6,8,9-tetrahydropyrimido[4,5-d]azepin-7-yl]methanone
C22H27N3O2 — CID 134791716
Data last refreshed: (MolForge compound catalog, from PubChem)
About Cyclopropyl-[4-(4-methoxyphenyl)-2-propan-2-yl-5,6,8,9-tetrahydropyrimido[4,5-d]azepin-7-yl]methanone
Cyclopropyl-[4-(4-methoxyphenyl)-2-propan-2-yl-5,6,8,9-tetrahydropyrimido[4,5-d]azepin-7-yl]methanone (PubChem CID 134791716) has the molecular formula C22H27N3O2 and a molecular weight of 365.48 g/mol. Its IUPAC name is cyclopropyl-[4-(4-methoxyphenyl)-2-propan-2-yl-5,6,8,9-tetrahydropyrimido[4,5-d]azepin-7-yl]methanone.
Molecular Properties
| Compound Name | Cyclopropyl-[4-(4-methoxyphenyl)-2-propan-2-yl-5,6,8,9-tetrahydropyrimido[4,5-d]azepin-7-yl]methanone |
|---|---|
| PubChem CID | 134791716 |
| Molecular Formula | C22H27N3O2 |
| Molecular Weight | 365.48 g/mol |
| Exact Mass | 365.21 |
| IUPAC Name | cyclopropyl-[4-(4-methoxyphenyl)-2-propan-2-yl-5,6,8,9-tetrahydropyrimido[4,5-d]azepin-7-yl]methanone |
| SMILES | COc1ccc(-c2nc(C(C)C)nc3c2CCN(C(=O)C2CC2)CC3)cc1 |
| InChI | InChI=1S/C22H27N3O2/c1-14(2)21-23-19-11-13-25(22(26)16-4-5-16)12-10-18(19)20(24-21)15-6-8-17(27-3)9-7-15/h6-9,14,16H,4-5,10-13H2,1-3H3 |
| InChIKey | FQXYWULPIDNTMJ-UHFFFAOYSA-N |
| XLogP | 3.61 |
| TPSA | 55.32 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 365.48 |
| LogP ≤ 5 | 3.61 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134791716 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.